NantHealth, Inc
NH was delisted on the 23rd of May, 2023.
44 hedge funds and large institutions have $9.81M invested in NantHealth, Inc in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 8 closing their positions.
664% more call options, than puts
Call options by funds: $344K | Put options by funds: $45K
2% less funds holding
Funds holding: 45 → 44 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
32% less capital invested
Capital invested by funds: $14.5M → $9.81M (-$4.69M)
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
+$457K |
| 2 |
Millennium Management
New York
|
+$185K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$100K |
| 4 |
BlackRock
New York
|
+$74.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$60.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$380K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$283K |
| 3 |
Renaissance Technologies
New York
|
-$134K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$130K |
| 5 |
JP Morgan Chase
New York
|
-$105K |
NH Hedge Fund Activity: Q3 2021 in Review
44 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q3 2021, worth a combined $9.81M — down 32% from $14.5M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NH and 7 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 11 added.
The largest buyer was B. Riley Wealth Management, opening a new position worth an estimated $457K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $380K sold.
- 44 institutional investors held NantHealth, Inc (NH) as of Q3 2021, down from 45 in Q2 2021.
- Funds reported $9.81M of NantHealth, Inc stock for Q3 2021, down 32% quarter-over-quarter.
- 7 funds opened new NantHealth, Inc positions in Q3 2021 and 8 closed out, a net change of -1 holder.
- The largest NantHealth, Inc buyer in Q3 2021 was B. Riley Wealth Management, an estimated $457K added.
- The largest NantHealth, Inc seller in Q3 2021 was GSA Capital Partners, an estimated $380K sold.
Based on aggregated 13F filings for Q3 2021.